TrialEuropean journal of cancer (Oxford, England : 1990)2019

Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma.

Alexander M M Eggermont et al.PubMed ↗Publisher ↗

No numbers read from the abstract.